About 2,900 women are diagnosed with cervical cancer every year in the UK.

It’s the second most common cancer in women under 35 with the human papilloma virus being the major cause.

In the UK, girls in Year 8 at school – aged 12 to 13 – are now offered the HPV vaccine, Cervarix.

The third dose of the vaccine for this year’s group is now ready for administration and research by the NHS has revealed the programme will prevent at least seven out of 10 cancers of the cervix and could defend against even more in the future.

But the vaccine programme is not immune to controversy and many parents argue that their daughters don’t need it if they are not sexually active.

However Dr Rosemary McCann, Consultant in Communicable Disease Control at the Health Protection Agency (HPA) in Eccles says: “This vaccine will save lives and it is just as crucial to administer it to young girls who are not yet sexually active as those who are.

“The HPV vaccine protects against the two strains of HPV (16 and 18) that cause cervical cancer.

“Many sexually active women can become infected with HPV but most will fight off the virus on their own. If it persists however, it can cause cancer cells to develop.

“Girls are protected against those strains if they receive the vaccine before becoming sexually active. However, if they receive the vaccine after being sexually active and have been infected by the two strains, they will not be immune.

“This is why it is equally important for a girl or young woman to have the vaccine if they have not yet had sex.”

Dr McCann is practising what she preaches. Her 16-year-old daughter has recently received the third dose of the vaccine, and she says they discussed the pros and cons with her daughter to enable her to come to an independent decision.

“As a mother I’m pleased she did have the vaccine because, as a doctor, I remember well treating a 29-year-old woman who died with cervical cancer,” she adds.

But last year parents were faced with another dilemma over the vaccine when a Coventry schoolgirl died just hours after being given Cervarix.

Fourteen year old Natalie Morton died in hospital in September and Coventry Primary Care Trust launched an immediate investigation. It was later discovered the schoolgirl died from a large malignant tumor in her chest.

At the time, doctors said Natalie’s condition was so severe she could have died at any point and they added that there was no indication the HPV vaccine was a contributing factor to her death.

Dr McCann is keen to reinforce that view. “Young people can and do die suddenly from natural causes,” she says, “and, although such tragedies are rare, they are more common than deaths as a reaction to routine medical treatment.

“Severe adverse reactions to vaccines are very rare.”

But will this allay the fears of parents over the vaccine? “A severe allergic reaction, known as an anaphylactic reaction, can occur following vaccination,” Dr McCann explains.

“This happens in about one in a million vaccinations and it’s important to point out that health professionals giving the vaccines are trained to treat such reactions promptly.

“According to national statistics, there has not been a single recorded death due to anaphylactic reaction following a vaccination for at least 10 years.”

And the national statistics are supported locally, adds Dr McCann. “Last year in Trafford, there were no severe reactions among 1,400 girls who received the HPV vaccine.”

Caste study – Kate McGough

Kate McGough is in year 12 of school and plans to study medicine.

She turns 17 next month and lives in Eccles with her parents and her 15-year-old brother.

Kate has just received her third dose of the HPV vaccine. She took the decision to have the vaccine despite there being no history of cancer in her family after a long discussion with her mother – Dr Rosemary McCann.

Kate says: “It was my own decision to have the vaccine. Of course I talked it over with my mum, just like any girl would, but I suppose with mum being a doctor she had more information - both personal and official - on hand.

“But I know other girls who’ve gone to their own GPs with questions about the vaccine. I did quite a bit of online research about the vaccine and was aware of the young girl dying in Coventry, but I was satisfied with the outcome of that particular investigation.

“I also remember Jade Goody’s death of cervical cancer and while many people felt she was wrong to live out her illness in the media, I think it helped a lot of young women realise how important it is to protect yourself as best you can against cervical cancer.

“She was so young and my mum has seen young women in their late 20s die from cervical cancer. If the HPV vaccine means I’m giving myself a better chance of not getting cervical cancer then I am 100 per cent sure I have done the right thing.

“And this is the message I’ve passed on to all my friends too.”

FACTFILE – HPV and the vaccine

THE VIRUS: The main types of cervical cancer are caused by HPV. You cannot see HPV and most who become infected don’t develop symptoms or even realise they have it.

THE VACCINE: The HPV vaccine programme started in September 2008 with all 12 to 13-year-old and 17 to 18-year-old girls being offered it.

Because the vaccine does not protect against ALL cervical cancers it is important for all girls to have cervical screening later in life (from the age of 25 in England).

RESEARCH: Research has revealed that if girls take up the vaccine, the programme will prevent at least seven out of 10 cancers of the cervix.

THE ARGUMENT FOR THE VACCINE: According to Cancer Research UK, three out of four mothers want their daughters to have the vaccine, while other research among parents reveals that 85 per cent are in favour.

THE ARGUMENT AGAINST THE VACCINE: Twelve per cent of parents and some religious groups say that giving a jab to 12, 13 and 14-year-olds will encourage promiscuity.

THE VACCINE PROGRAMME: More than one million girls have been given the Cervarix vaccine since the start of the initiative in September 2008.

Each girl receives three separate jabs over a six month period. By July 2011, over two million girls will have been offered the HPV vaccine.

MORE INFORMATION: Visit immunisation.nhs.uk/Vaccines/HPV